Published by
@ShahidNShah
@ShahidNShah
Trump tries to lure CureVac to make a 'U.S. vaccine,' but German government steps in
It’s a pretty extraordinary story that started off with a CEO exiting a biotech and has now become about the U.S. president allegedly wanting to lure that biotech over to the U.S. to build a vaccine for the coronavirus—but just for Americans.
Maybe it was something he said after all: After meeting President Donald Trump in early March, CureVac’s CEO Daniel Menichella abruptly left, leaving its old chief back in charge and a lot of unanswered questions.
No reason was given, but the circumstances were strange, given the German mRNA biotech is working on a vaccine against COVID-19, Menichella had taken the top spot only a few years back and has been doing a pretty good job since.
Continue reading at fiercebiotech.com
Make faster decisions with community advice
- Did a Biogen staffer take her COVID-19 infection on a plane to Beijing?
- 10 Digital Health Technology Solutions for Global COVID-19 Response
- Coronavirus 'fearware' sees hackers exploit Covid-19 panic to target victims
- Coronavirus (COVID-19) – 5 things you can do to protect yourself and your community
- Coronavirus vaccine clinical trial starting without usual animal data
Next Article
-
Did a Biogen staffer take her COVID-19 infection on a plane to Beijing?
A Biogen management meeting held in Boston in late February has A Biogen management meeting held in Boston in late February has spawned 108 confirmed or presumptive positive cases of the novel …
Posted Mar 17, 2020coronavirustrump administration
